FibroGen (FGEN) Misses Q3 EPS by 15c
Get Alerts FGEN Hot Sheet
Join SI Premium – FREE
FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.50), $0.15 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $29.03 million versus the consensus estimate of $36.48 million.
For earnings history and earnings-related data on FibroGen (FGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- MetroCity Bankshares, Inc. (MCBS) Tops Q1 EPS by 4c
- Park National Corp. (PRK) Tops Q1 EPS by 36c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!